Search

everythinglearnresearchcommunity

for

Search:↓

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

Golvatinib shows promise as a treatment for Omicron in elderly patients.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Compound 1 showed promising anticancer activity.

Enhancing immune response can improve cancer treatment effectiveness.

Monitor for early signs of myelosuppression, like hair loss, in patients on azathioprine to manage side effects.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

Tofacitinib and oral minoxidil together effectively regrow hair in severe alopecia areata patients.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

Vismodegib effectively treats advanced basal cell carcinoma but requires careful management of serious side effects.

Mogamulizumab treatment in Sézary syndrome may cause skin issues and hair loss but can lead to a complete response.

Ripretinib is effective and safe for treating advanced GIST in Chinese patients, particularly for non-gastric GISTs.

Iontophoresis improves minoxidil delivery for alopecia treatment.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

PLD is an effective and safer alternative for treating breast cancer.

Most pediatric cancer patients at Muhimbili National Hospital experienced adverse drug reactions during chemotherapy, highlighting the need for careful monitoring.

Tumor-targeted drug carriers can improve chemotherapy precision and reduce side effects.

Both treatments are similarly effective, but paclitaxel-carboplatin is cheaper and has more severe side effects.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Blocking YAP/TAZ could be a new way to treat skin cancer.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.